
"Citi's upgrade centers on a significant upward revision to commodity chemical forecasts driven by the Iran conflict and the closure of the Strait of Hormuz, which is disrupting global chemical capacity and shipments. The geopolitical pressure is real: prediction markets are pricing a 99.95% probability of Iran closing the Strait by year-end 2026, backed by over $51 million in total trading volume."
"Celanese's Acetyl Chain segment, which posted $940 million in Q4 2025 revenue, down 15% year over year, is most exposed to feedstock dynamics. A sustained oil and energy price spike compresses global acetic acid supply, potentially restoring pricing power and margin for integrated producers like Celanese."
"Despite a difficult 2025, Celanese generated $773 million in free cash flow, up 45.57% year over year, and is targeting $650 to $750 million in 2026. That cash engine supports ongoing deleveraging and positions the company to compound value through the cycle."
Celanese Corporation has recovered sharply in 2026, gaining 35.77% year-to-date despite being down 66% from its January 2022 peak. Citi upgraded the stock to $81 from $75, citing upward revisions to commodity chemical forecasts driven by Iran conflict and Strait of Hormuz closure disrupting global chemical capacity. The Acetyl Chain segment, which generated $940 million in Q4 2025 revenue, stands to benefit from sustained oil price spikes that compress acetic acid supply and restore pricing power. Celanese demonstrated strong free cash flow discipline with $773 million generated in 2025, up 45.57% year-over-year, targeting $650-$750 million in 2026. Balance sheet improvements include the Micromax divestiture proceeds of $500 million and a new $1.75 billion revolving credit facility extending through 2030, reducing refinancing risk.
#celanese-stock-recovery #commodity-chemical-pricing #geopolitical-supply-disruption #free-cash-flow-generation #balance-sheet-stabilization
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]